Document Detail


Comparison of gemeprost and vaginal misoprostol in first trimester mifepristone-induced abortion.
MedLine Citation:
PMID:  15964289     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The aim of this study was to compare efficacy and side effects of gemeprost and vaginal misoprostol in mifepristone-induced abortions in women up to 63 days of gestation. METHODS: A retrospective study of 833 consecutive patients admitted for medical termination of first trimester pregnancy was conducted. Four-hundred ten patients received mifepristone 600 mg, followed 48 h later by gemeprost 1 mg (regimen I), and 423 patients received mifepristone 200 mg followed by vaginal misoprostol 800 microg (regimen II). Success rates were evaluated after 2 weeks and after 3 months. The severity of bleeding and side effects (pain, nausea, vomiting and diarrhea) was scored by the patients, and requests for supplementary analgesic treatment were recorded by the attending nurse. RESULTS: Success rates were 99% in both groups after 2 weeks of follow-up. At 3 months of follow-up, success rates had declined to 94% for regimen I and 96% for regimen II. The frequency of severe pain was higher in regimen I compared to regimen II (72% vs. 60%, p < .001), but the severity of bleeding and gastrointestinal side effects was similar in the two regimens. CONCLUSION: When combined with mifepristone, gemeprost and vaginal misoprostol are equally effective for termination of first trimester abortion, but may be associated with varying intensity of side effects.
Authors:
Pernille Fog Svendsen; Christina Rørbye; Thomas Vejborg; Lisbeth Nilas
Related Documents :
11105539 - Double-blind randomized dose-finding study in acute vulvovaginal candidosis. comparison...
8916999 - A randomised comparison of oral and vaginal misoprostol for cervical priming before suc...
16505969 - Management of haemorrhagic type moyamoya disease with intraventricular haemorrhage duri...
2658609 - Single-dose prophylaxis in patients undergoing vaginal hysterectomy: cefamandole versus...
7471129 - A comparison of a three-day and seven-day clotrimazole regimen for vulvovaginal candidi...
21043369 - Evaluation of patients' satisfaction of cervical ripening using dinoprostone by either ...
20103449 - Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized p...
21828109 - Mechanical versus chemical pleurodesis for management of primary spontaneous pneumothor...
11191939 - Protective effect of unstable angina in coronary artery bypass surgery.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Contraception     Volume:  72     ISSN:  0010-7824     ISO Abbreviation:  Contraception     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-06-20     Completed Date:  2005-11-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0234361     Medline TA:  Contraception     Country:  United States    
Other Details:
Languages:  eng     Pagination:  28-32     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Copenhagen University Hospital, 2650 Hvidovre, Copenhagen, Denmark. pernillefsvendsen@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage*,  adverse effects
Abortion, Induced*
Adult
Alprostadil / administration & dosage,  adverse effects,  analogs & derivatives*
Chorionic Gonadotropin / blood
Female
Gestational Age*
Humans
Misoprostol / administration & dosage*,  adverse effects
Pregnancy
Retrospective Studies
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0/Chorionic Gonadotropin; 59122-46-2/Misoprostol; 64318-79-2/gemeprost; 745-65-3/Alprostadil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
Next Document:  The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical r...